Cocculine® + placebo
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Breast Cancer
Conditions
Breast Cancer
Trial Timeline
Sep 1, 2005 → Oct 1, 2008
NCT ID
NCT00409071About Cocculine® + placebo
Cocculine® + placebo is a phase 3 stage product being developed by Boiron for Breast Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT00409071. Target conditions include Breast Cancer.
What happened to similar drugs?
20 of 20 similar drugs in Breast Cancer were approved
Approved (20) Terminated (4) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00409071 | Phase 3 | Completed |
Competing Products
20 competing products in Breast Cancer